Contract ManufacturingEUR 1.0billion
Innovation drives us at Boehringer Ingelheim as we strive to positively impact lives of humans and animals with our innovative solutions. In 2022 we were able to help more people than ever before.
The excitement about our growing pipeline and the success of our current portfolio, for patients and animals alike, makes us confident about the future, and we are energized to continue to transform lives for generations and reach even more people who will benefit from our products.
Hubertus von Baumbach, Chairman of the Board of Managing Directors
Two very different Boehringer Ingelheim employees share, how they are very similar in terms of the values they appreciate.Read More
AMR poses a serious threat to global health. Boehringer Ingelheim strives to bring about a decisive shift in the battle against resistant bacteria.Read More
Cardio, renal and metabolic diseases can have complex interdependencies. Some of them can be treated with the same medicine.Read More
A four-piece collection from Dutch fashion designer Bart Hess visualizes the painful experience of people living with generalized pustular psoriasis (GPP).Read More
There is a close connection between humans and animals when it comes to their health and wellbeing. An interview with Clive Wood and Eric Haaksma.Read More